
    
      Multi-centre, double-blind, randomised and stratified parallel group study to compare the
      efficacy and safety of fluticasone propionate 500 mcg bd versus salmeterol/fluticasone
      combination 50/250 mcg bd both via Diskus inhaler during 1 year in Chronic Obstructive
      Pulmonary Disease(COPD) patients with a partially reversible obstruction.
    
  